TechCrunch

SEPTEMBER 9, 2021

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Neuroglee gets $2.3 Venture investing in elder tech.

digital therapeutics 93

digital therapeutics startup health support 93

American Entrepreneurship

JUNE 20, 2024

With clearance by the FDA and reimbursement by Medicare and commercial insurance, JOGO’s funding round enables them to expand the $380B treatment market without drugs or surgery. JOGO is the first-ever digital therapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases.

health 90

health digital therapeutics hospitality entrepreneurship 90

TechCrunch

NOVEMBER 3, 2021

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

digital therapeutics 116

digital therapeutics health ventures enablement 116

TechCrunch

JULY 8, 2022

Moving Analytics founders and undergraduate friends Harsh Vathsangam and Shuo Qiao met their third co-founder, Ade Adesanya, at the University of Southern California. Moving Analytics founders outside their Irvine office. Left to right: Joe Villanueva, Ade Adesanya, Harsh Vathsangam, Shuo Qiao. Image Credits: Moving Analytics.

health 92

health startup enablement ventures 92

AsiaTechDaily

FEBRUARY 17, 2022

It will also use the proceeds to expand in digital therapeutics, insurance, and international markets. About GOQii Founded in 2014 by Abhishek Sharma, Sachin Janghel, Champ Alreja, and Vishal Gondal, GOQii is a smart-tech-enabled healthcare platform that offers wearable fitness bands, diagnostics, and personal coaching.

digital therapeutics 52

digital therapeutics health startup enablement 52

Y Combinator

MARCH 2, 2021

One of the most common topics YC Bio founders ask us about is the US Food and Drug Administration (FDA), and the broader regulatory environment. But as a starting point, we wanted to touch on some of the most important concepts bio founders should think about. Emerging Therapeutic Areas. Conclusion.

startup 61

startup health development digital therapeutics 61